Stroke: trial by jury.
Trials of pharmacological intervention for acute stroke show several points of similarity with legal trials by jury. The relationships between sponsoring organisation and regulatory authorities and the roles of the many other participants are described. Only through a partnership can the common aim of developing improved treatment for patients with stroke be realised. Excellent structures and procedures have recently developed which minimise the risk of undertaking impractical, invalid or unreported trials. This will lead to greater confidence in our ability to identify a successful treatment and to discount worthless approaches.
Lees
Kennedy R
KR
University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow G11 6NT, Scotland, UK. k.r.lees@clinmed.gla.ac.uk
D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D010875:Pipecolic Acids / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*
D018691:Excitatory Amino Acid Antagonists; D010875:Pipecolic Acids; C053672:selfotel